Related Experiment Videos
BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization
Salvatore C Ruffolo1, Gordon C Shore
1Department of Biochemistry, McGill University, Montreal, Quebec H3G 1Y6, Canada.
Abstract:
Caspase-8 cleaves BID to tBID, which targets mitochondria and induces oligomerization of BAX and BAK within the outer membrane, resulting in release of cytochrome c from the organelle. Here, we have initiated these steps in isolated mitochondria derived from control and BCL-2-overexpressing cells using synthetic BH3 peptides and subsequently analyzed the BCL members by chemical cross-linking. The results show that the BH3 domain of BID interacts with and induces an "open" conformation of BAK, exposing the BAK N terminus. This open (activated) conformer of BAK potently induces oligomerization of non-activated ("closed") conformers, causing a cascade of BAK auto-oligomerization. Induction of the open conformation of BAK occurs even in the presence of excess BCL-2, but BCL-2 selectively interacts with this open conformer and blocks BAK oligomerization and cytochrome c release, dependent on the ratio of BID BH3 and BCL-2. This mechanism of inhibition by BCL-2 also occurs in intact cells stimulated with Fas or expressing tBID. Although BID BH3 interacts with both BCL-2 and BAK, the results indicate that when BCL-2 is in excess it can sequester the BID BH3-induced activated conformer of BAK, effectively blocking downstream events. This model suggests that the primary mechanism for BCL-2 blockade targets activated BAK rather than sequestering tBID.
Insights
BCL-2 protein inhibits apoptosis by blocking BAK activation. Excess BCL-2 sequesters activated BAK, preventing cytochrome c release and cell death, even when BID initiates BAK opening.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- Caspase-8 initiates apoptosis by cleaving BID to tBID.
- tBID targets mitochondria, inducing BAX and BAK oligomerization and cytochrome c release.
Purpose of the Study:
- To investigate the mechanism of BCL-2 in inhibiting apoptosis.
- To analyze the interaction between BID BH3, BAK, and BCL-2 in isolated mitochondria and intact cells.
Main Methods:
- Isolated mitochondria from control and BCL-2-overexpressing cells were used.
- Synthetic BH3 peptides initiated apoptosis-related events.
- Chemical cross-linking analyzed BCL members' interactions.
Main Results:
- BID BH3 domain induces an "open" conformation of BAK, exposing its N terminus.
- This activated BAK triggers a cascade of auto-oligomerization.
- BCL-2 selectively binds to activated BAK, blocking oligomerization and cytochrome c release, dependent on BCL-2 and BID BH3 ratio.
Conclusions:
- BCL-2's primary inhibition mechanism targets activated BAK, not tBID.
- Excess BCL-2 effectively sequesters activated BAK, halting downstream apoptotic events.
- This mechanism is validated in both isolated mitochondria and intact cells stimulated with Fas or expressing tBID.